Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

No more finger pricks? wearable sensor and phone coaching tested for older diabetics

NCT ID NCT06783907

Disease control Sponsor: Hong Kong Metropolitan University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested a new way to help people aged 60 and older with type 2 diabetes manage their condition. Instead of traditional finger-prick blood tests, participants wore a non-invasive sensor on their wrist to track glucose levels. They also received personalized coaching via phone or WhatsApp. The goal was to see if this tech-based approach could improve blood sugar control and make self-care easier. Sixty people took part, and the results will compare the new method to standard monitoring.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Non-invasive wearable glucose monitoring device and personalized care coaching
What this could lead to
If successful, this approach could offer a more comfortable and convenient way for older adults to monitor their blood sugar and improve diabetes self-management.
What could go wrong
This was a small feasibility study with only 60 participants, so results may not apply to everyone. The device and coaching may not lead to lasting improvements in blood sugar control.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Dec 2023

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. aged ≥ 60 years old; 2. patients diagnosed with Type II DM without insulin injections; 3. patients experienced hypo (histix \< 4.0 mmol/L) or hyperglycemia (histix * 16.0 mmol/L); \& 2\. The Abbreviated Mental Test (AMT) ≥ 6. Exclusion Criteria: 1. patient on dialysis; 2. taking ascorbic acid \> 500mg daily or (Not recommended by manufacturer as result may be affected); 3. taking salicylic acid ≥ 650mg single dose or (Not recommended by manufacturer as result may be affected); or 4. scheduled radiological therapy during CGM application (Not recommended by manufacturer as result may be affected).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetes mellitus are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

diabetes mellitus type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diabetes mellitus

Contacts and locations

Locations

  • LEI FOOK Neighbourhood Elderly Centre

    Hong Kong, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.